New scan could sharpen cancer picture for surgeons
NCT ID NCT03631017
Summary
This study is testing a new imaging drug called PARPi-FL to see if it can help doctors get clearer pictures of head and neck cancer. It involves 12 adult patients with confirmed cancer who are scheduled for surgery at Memorial Sloan Kettering. The main goal is to check the safety of the drug and see how well it highlights cancer in PET scans compared to standard imaging.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.